Leo Takaoka

Leo Takaoka has worked in various roles in the field of IP and patent counsel since 2007. Starting as a Senior Scientist at Schering-Plough Research Institute, they then moved to Scientist I, Department of Medicinal Chemistry at Millennium: The Takeda Oncology Company in 2009. In 2012, they were a Scientist, Department of Medicinal Chemistry at CoMentis, Inc., and also a Technology Specialist at WilmerHale LLP. In 2015, they were a Technology Specialist at Hamilton, Brook, Smith & Reynolds, P.C., and a Technical Advisor at Cooley LLP in 2016. From 2018 to 2019, they were a Technology Specialist at Foley Hoag LLP, and is currently a Director of IP and Patent Counsel at both Elektrofi and mytide Therapeutics.

Leo Takaoka attended UC Irvine from 1995-1998, where they earned a Bachelor of Arts (BA) in both Chemistry and Biology, General. Leo then continued their studies at UC Irvine, receiving a Ph.D. in Organic Chemistry in 2004. Following this, they worked as a Postdoctoral Fellow at Scripps Research from 2004-2007, specializing in Organic Synthesis. Finally, they attended Suffolk University Law School from 2013-2017, earning a Doctor of Law (J.D.).